Although DT delivered solid revenue growth in Q2, the group EBIT fell short of our low expectations. Short-term outlook in medical is uncertain while security solutions are expected to see strong growth from Q3’23 onwards. We expect a significant improvement in EBITA in the coming years.
LÄS MER